Imatinib Terminated Phase 2 Trials for Melanoma Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00421317Imatinib in Adult Patients With Metastatic Ocular Melanoma